Home › Funds › Townsend & Associates, Inc › EW

Townsend & Associates, Inc position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Townsend & Associates, Inc reported holding 206,533 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$17.9M, representing 1.51% of its reported portfolio and ranking #29 among its reported holdings. Townsend & Associates, Inc has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)206.53K sh
Reported value held$17.89M
Portfolio Weight1.51%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Townsend & Associates, Inc's EW position evolved

Townsend & Associates, Inc first disclosed a stake in EW in Q3 2023 at 76,404 shares (US$4.7M). The position peaked in Q3 2026 at 206,533 shares, worth US$17.9M. Across 13 filings, Townsend & Associates, Inc increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 206,533 shares valued at US$17.9M — an increase of 3,132 shares quarter over quarter.. Notable position changes include a 110% increase in Q4 2023 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 76.40K $4.71M New
Q4 2023 160.71K $11.66M Add
Q1 2024 162.58K $14.27M Add
Q2 2024 166.54K $10.39M Add
Q3 2024 174.98K $12.36M Add
Q4 2024 180.75K $12.65M Add
Q1 2025 214.80K $14.86M Add
Q2 2025 184.18K $14.73M Reduce
Q3 2025 190.33K $14.21M Add
Q4 2025 193.66K $16.36M Add
Q1 2026 199.47K $16.26M Add
Q2 2026 203.40K $17.29M Add
Q3 2026 206.53K $17.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Townsend & Associates, Inc held EW?

Townsend & Associates, Inc has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Townsend & Associates, Inc's current position in EW?

As of Q3 2026, Townsend & Associates, Inc holds 206.53K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $17.89M, representing 1.51% of its reported portfolio and ranking #29.

Has Townsend & Associates, Inc been buying or selling EW?

In the latest 13F filing (Q3 2026), Townsend & Associates, Inc increased its position in EW. The position peaked in Q3 2026 at 206.53K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.